Furthermore, a significant correlation was found between S100A10 expression and extrathyroidal extension (p = 0.005), lymph node metastasis (p = 0.013), and ATA recurrence risk (p = 0.023). The gene discussed is S100A10; the disease is metastatic malignant neoplasm in the lymph nodes.